Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy), with a Gleason Score and PSA level recorded
- People who have had their prostate surgically removed and whose doctor has recommended radiation treatment to the area where the prostate was, either as a precaution or to treat signs of returning cancer
- People who have a reasonably good level of physical functioning, as measured by a standard performance scale (Karnofsky Index of 70% or above) (confirm with trial site)
- People who are 18 years of age or older
Who may not be able to join:
- People who are currently receiving hormone therapy to reduce androgen (male hormone) levels
- People whose cancer has spread to the lymph nodes
- People who have visible tumour remaining after surgery, or where the surgeon was unable to remove all of the cancer (confirm with trial site)
- People whose cancer has spread to other parts of the body (stage IV / M1)
- People who have previously received radiation therapy to the relevant area
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Juergen Debus, University Hospital Heidelberg
Phone: 06221 56 8201
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quality of life (prostate-associated, 12 weeks vs baseline)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.